Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition

ClinicalTrials.gov ID: NCT03926117

Public ClinicalTrials.gov record NCT03926117. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 10:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Patients with chronic kidney disease, who have evidence of systemic inflammation with increased cardiovascular risk, will be enrolled into this trial. The purpose of this trial is to determine a dose to select for a potential cardiovascular outcome trial with Ziltivekimab. Doses to be tested will be 7.5 mg, 15 mg and 30 mg subcutaneous monthly compared to placebo for six months.

Study identification

NCT ID
NCT03926117
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
264 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 3, 2019 (Actual)
Primary completion
Jun 26, 2020 (Actual)
Completion
Jun 26, 2020 (Actual)
Last update posted
Dec 31, 2025

2019 – 2020

United States locations

U.S. sites
49
U.S. states
23
U.S. cities
43
Facility City State ZIP Site status
Central Alabama Research Birmingham Alabama 35205 —
Aventiv Research Mesa Arizona 85210 —
Arizona Kidney Disease and Hypertension Center Phoenix Arizona 85016 —
Elite Clinical Studies Phoenix Arizona 85018 —
North America Research Institute Lynwood California 90262 —
North America Research Institute Riverside California 92503 —
Apex Research of Riverside Riverside California 92505 —
North America Research Institute San Dimas California 91773 —
Western Nephrology and Metabolic Bone Disease, PC Arvada Colorado 80002 —
AMPM Research Clinic Miami Florida 33169 —
Ocala Cardiovascular Research Ocala Florida 34474 —
Florida Premier Research Institue, LLC Winter Park Florida 32789 —
Southeastern Clinical Research Institute, LLC Augusta Georgia 30901 —
Columbus Regional Research Institute Columbus Georgia 31904 —
Investigator Research by Design, LLC Chicago Illinois 60643 —
University of Iowa Iowa City Iowa 52242 —
Clinical Trials of America, LLC - West Monroe Monroe Louisiana 71201 —
Capital Nephrology Greenbelt Maryland 20770 —
Onyx Clinical Research Caro Michigan 48723 —
Henry Ford Health System Detroit Michigan 48202 —
St. Clair Nephrology Research Roseville Michigan 48066 —
Nephrology Research of Michigan Saint Clair Shores Michigan 48081 —
DaVita Clinical Research Minneapolis Minnesota 55404 —
Julia and Israel Waldbaum Dialysis Center Great Neck New York 11021 —
Northport VAMC Northport New York 11768 —
DaVita Clinical Research The Bronx New York 10461 —
Mountain Kidney and Hypertension Associates Asheville North Carolina 28801 —
Metrolina Nephrology Associates, PA Charlotte North Carolina 28207 —
Metrolina Nephrology Associates Charlotte North Carolina 28277 —
Southeastern Nephrology - Whiteville Whiteville North Carolina 28472 —
Southeastern Nephrology Associates - Wilmington Wilmington North Carolina 28401 —
Summit Research Group, LLC Stow Ohio 44224 —
Northeast Clinical Research Center Allentown Pennsylvania 18104 —
Rhode Island Hospital Providence Rhode Island 02903 —
Piedmont Research Partners, LLC Fort Mill South Carolina 29707 —
Mountain View CLinical Research - Greer Greer South Carolina 29651 —
Knoxville Kidney Center, PLLC Knoxville Tennessee 37923 —
Nephrology Associates, PC Nashville Tennessee 37205 —
Renal Disease Research Institute Dallas Texas 75246 —
Vilo Research Group, Inc Houston Texas 77017 —
Biopharma Informatick Inc. Research Center Houston Texas 77043 —
Juno Research, LLC - Northwest Houston Texas 77070 —
North Hills Medical Research, Inc North Richland Hills Texas 76180 —
Clinical Advancement Center, PLLC San Antonio Texas 78212 —
San Antonio Kidney Disease Center Physicians Group, PLLC San Antonio Texas 78229 —
University of Vermont Burlington Vermont 05401 —
Southside Urology and Nephrology Danville Virginia 25241 —
Manassas Clinical Research Center Manassas Virginia 20110 —
Clinical Investigation Specialist, Inc Kenosha Wisconsin 53142 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03926117, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 31, 2025 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03926117 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →